Email Us
View Reports

CKD Bio Corporation Company Profile - Overview, History, SWOT Analysis, Products/Services, Facts, Financials, Key Executives, Competitors, Tech Intelligence, IT Outsourcing, IT Management, Recent Developments and Strategy Evaluation

  • ID : 5881344  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 34   |  
  • Publisher : Market Data Forecast

CKD BiO Corp (CKD) is a South Korea-based company, which manufactures and develops pharmaceutical raw materials and provides contract manufacture and research services for pharmaceutical products. The company is also engaged in the import and export of pharmaceutical products. The company primarily offers products such as antibiotic, lactamase inhibitor, antituberculosis, antidiabetic, immunosuppressant , antihyperlipidemic and intermediate. CKD's manufactures Antibiotic’s such as Demeclocycline Hydrochloride ( a Tetracycline antibiotic used as an intermediate for Minocycline Hydrochloride), Rifamycin SV Sodium ( an antibiotic for parenteral use), Teicoplanin (A glycopeptides antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria) and Vancomycin Hydrochloride ( a glycopeptides antibiotic used in the prophylaxis and treatment of infections). CKD's manufactures β-lactamase inhibitor Potassium Clavulanate; Rifampicin (An antituberculotic for oral use); Acarbose ( a antidiabetic used to treat type II diabetes mellitus as α-glucosidase inhibitor); Cyclosporine (An immunosuppressant & for treatment of Rheumatoid arthritis, Aplastic anemia, Nephrotic syndrome); Antihyperlipidemic such as Lovastatin ( a HMG CoA reductase inhibitor); Intermediate such as Rifamycin O ( an intermediate for Rifaximin). CKD’s services include contract research (CRO) and contract manufacturing (CMO). In contract research (CRO) the company offers novel process development, optimization from lab to pilot scale in fermentation, purification and semi-synthesis, development of analytical methods and validation, Impurity characterization and stability testing. The CRO is offered through CKD Bio. In contract manufacturing (CMO) the company offers multipurpose isolation, purification, process fine tuning and optimal scaled operations to various APIs & intermediates at cGMP facility. CKD’s probiotics include Lactobacillus, Bifidobacterium and Cocci. In lactobacillus the company offers casei, fermentum, gasseri, plantarum, reuteri and salivarius. In Bifidobacterium the company offers bifidum, lactis, breve and longum. In cocci the company offers feacium, feacalis, lactis and pentosaceus. CKD Bio is engaged in international trading for the third party products across 80 countries such as Africa, Europe, the Middle East, Asia, South America and North America.

Scope of the Report

-- About the Company - Historical Details, Current Ownership Structure and basic overview of CKD Bio Corporation in terms of revenue, net income, and operating income.

-- Financials - Details about CKD Bio Corporation listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.

-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.

-- Company SWOT Analysis - Outlines CKD Bio Corporation’s strengths, weaknesses, and opportunities and threats facing the company.

-- Recent Developments - Showcases CKD Bio Corporation’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.

-- Strategic Evaluation - Provides an overview of CKD Bio Corporation’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.

-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.

Key Questions Answered

-- What domain does CKD Bio Corporation operate and what are key points about it?

-- What is the product / service portfolio of CKD Bio Corporation?

-- How has CKD Bio Corporation performed financially from the 2013?

-- How does CKD Bio Corporation rank among its peers in terms of revenue and market share?

-- What are CKD Bio Corporation strengths and weaknesses and what opportunities and threats does it face?

-- What are CKD Bio Corporation’s main growth strategies and how successful has the company been at implementing them?

-- What is the in-house technical capability of CKD Bio Corporation? Where does it procure / outsource it?

Reasons to buy

-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own

-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost

-- 12 hour delivery time fulfilling your urgent requests as per your requirement

-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics

1. About the Company

1.1 History and Basic Facts

1.2 Ownership Structure and Key Executives

1.3 Head Office

1.4 Other Locations & Subsidiaries

1.5 List of Competitors

1.6 Employee Count & Distribution

2. Financials

2.1 Company Type (Listed / Unlisted)

2.2 Annual Statements

2.3 Key Financial Highlights

2.4 Region-wise Breakdown

3. Product / Services

3.1 Overview

3.2 Description

4. SWOT Analysis

4.1 SWOT Overview

4.2 Strengths

4.3 Weaknesses

4.4 Opportunities

4.5 Threats

5. Recent Developments

5.1 Mergers & Acquisitions

5.2 Partnerships, Collaborations & Joint Ventures

5.3 New Product Launches

5.4 Business Expansion / Divestment

6. Strategic Evaluation

6.1 Corporate Strategy

6.2 Legal Issues

6.3 Analyst Outlook

7. Technology Landscape

7.1 Industry

-- 7.1.1 Industry Snapshot

-- 7.1.2 IT Spend

-- 7.1.3 Key Information Technology Trends

7.2 Company

-- 7.2.1 IT Overview

-- 7.2.2 Key IT Technologies

-- 7.2.3 Recent IT Initiatives

-- 7.2.4 IT Outsourcing Engagements

-- 7.2.5 Key IT Management

-- 7.2.6 CIO/CTO Profile


-- Methodology

-- About Us

-- Contact Us

-- Disclaimer

Fig.1: Company Snapshot

Fig.2: Locations Listing on Map

Table.1: Ownership Structure

Table.2: List of Competitors

Table.3: Annual Statements

Table.4: Key Financial Highlights

Table.5: Region-wise Breakdown

Table.6: Product/Services Overview

Table.7: Mergers & Acquisitions

Table.8: Partnerships, Collaborations & Joint Ventures

Table.9: New Product Launches

Table.10: Business Expansion / Divestment

Table 11: IT Budgets

Table 12: Key IT Management (CIO / CTO)

Table 13: IT Deals undertaken in the past years

Purchase this Market Research Report


Call us on : +1 888 709 8757

Drop us an email at :